Edition:
United States

Seres Therapeutics Inc (MCRB.OQ)

MCRB.OQ on NASDAQ Stock Exchange Global Select Market

9.84USD
14 Dec 2017
Change (% chg)

$-0.24 (-2.38%)
Prev Close
$10.08
Open
$10.13
Day's High
$10.13
Day's Low
$9.70
Volume
99,364
Avg. Vol
63,734
52-wk High
$17.33
52-wk Low
$8.86

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 23.01 -0.171
Jun '17 3.01 -0.694
Mar '17 3.02 -0.631
FY 2016 Dec '16 3.04 -0.626
Sep '16 13.02 -0.464
Jun '16 3.00 -0.705
Mar '16 0.00 -1.308
FY 2015 Dec '15 0.00 -0.500
Sep '15 0.00 -0.375
Jun '15 0.00 -1.453
Mar '15 0.00 -0.211
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 7 2.57 3.00 0.00 4.00
Quarter Ending Mar-18 2 13.00 23.00 3.00 --
Year Ending Dec-17 7 31.60 32.05 29.04 19.34
Year Ending Dec-18 8 16.01 42.00 0.00 20.39
Earnings (per share)
Quarter Ending Dec-17 7 -0.74 -0.67 -0.81 -0.83
Quarter Ending Mar-18 3 -0.51 -0.16 -0.73 --
Year Ending Dec-17 7 -2.24 -2.16 -2.31 -2.47
Year Ending Dec-18 8 -2.68 -1.70 -3.73 -2.71
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 190.77 35.50
P/E High - Last 5 Yrs. -- 277.36 45.22
P/E Low - Last 5 Yrs. -- 92.80 24.21
Beta -- 0.82 0.91
Price to Sales (TTM) 12.43 117.72 5.89
Price to Book (MRQ) 4.66 21.83 5.66
Price to Tangible Book (MRQ) 4.66 25.81 7.25
Price to Cash Flow (TTM) -- 103.69 24.38
% Owned Institutions 79.91 5.72 1.41

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.49
Dividend Yield - 5 Year Avg -- 0.26 2.05
Dividend 5 Year Growth Rate -- 2.00 5.25
Payout Ratio(TTM) -- 98.06 46.15

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 76.83 -3.06 6.81
Sales (TTM) vs TTM 1 Yr. Ago 71.28 30.14 5.59
Sales - 5 Yr. Growth Rate -- 33.20 10.23
EPS (MRQ) vs Qtr. 1 Yr. Ago 63.13 -148.11 7.98
EPS (TTM) vs TTM 1 Yr. Ago 1.58 -- --
EPS - 5 Yr. Growth Rate -- 43.94 10.93
Capital Spending - 5 Yr. Growth Rate -- 41.00 15.14

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.55
Current Ratio (MRQ) 6.53 5.70 3.57
LT Debt to Equity (MRQ) 11.02 14.63 13.37
Total Debt to Equity (MRQ) 11.02 17.10 19.35
Interest Coverage (TTM) -- -135.87 44.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 44.20 54.91
Gross Margin - 5 Yr. Avg. -- 55.70 52.46
EBITD Margin (TTM) -250.13 -- --
EBITD - 5 Yr. Avg -- -219.33 15.51
Operating Margin (TTM) -272.11 -637.28 6.68
Operating Margin - 5 Yr. Avg. -- -236.27 10.99
Pre-Tax Margin (TTM) -267.15 -607.21 7.52
Pre-Tax Margin - 5 Yr. Avg. -- -236.41 11.40
Net Profit Margin (TTM) -267.15 -604.71 3.74
Net Profit Margin - 5 Yr. Avg. -- -239.71 7.69
Effective Tax Rate (TTM) -- 15.46 24.27
Effective Tax Rate - 5 Yr. Avg. -- 19.04 24.07

Efficiency

  Company industry sector
Revenue/Employee (TTM) 252,598 21,870,754 851,754,569
Net Income/Employee (TTM) -674,827 -1,731,043 99,535,212
Receivable Turnover (TTM) -- 26.18 6.13
Inventory Turnover (TTM) -- 2.65 3.55
Asset Turnover (TTM) 0.13 0.43 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -33.65 -9.33 11.32
Return on Assets - 5 Yr. Avg. -- 0.11 12.28
Return on Investment (TTM) -38.05 -11.61 14.44
Return on Investment - 5 Yr. Avg. -- 3.32 16.08
Return on Equity (TTM) -71.57 -35.87 16.05
Return on Equity - 5 Yr. Avg. -- 5.69 17.28
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 1.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Seres Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 5.58 2.94 71 95
13 Week -31.38 -35.43 14 74
26 Week -1.60 -9.75 53 58
52 Week 9.45 -7.00 59 61
YTD -0.61 -16.09 51 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.92%
# of Holders: 129
Total Shares Held: 32,390,071
3 Mo. Net Change: 443,810
# New Positions: 13
# Closed Positions: 12
# Increased Positions: 58
# Reduced Positions: 35
# Net Buyers: 23
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.